The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To quantify and compare direct costs, utilization, and the rate of comorbidities in a sample of patients with fibromyalgia (FM), a poorly understood illness associated with chronic widespread pain that is commonly treated by rheumatologists, to patients with rheumatoid arthritis (RA), a well studied rheumatologic illness associated with inflammatory joint pain. Patients with both illnesses were isolated and reported as a third group. A secondary analysis of work loss was performed for an employed subset of these patients. RESEARCH DESIGN AND METHODS: Retrospective cohort analysis of Thomson Reuters MarketScan administrative healthcare claims and employer-collected absence and disability data for adult patients with a diagnosis of FM (ICD-9-CM 729.1) and/or RA (ICD-9-CM 714.0x,-714.3x) on at least one inpatient or two outpatient claims during 2001-2004. MAIN OUTCOME MEASURES: The 12-month healthcare utilization, expenditures, and rates of comorbidities were quantified for all study-eligible patients; absence and short-term disability days and costs were quantified for an employed subset. RESULTS: The sample included 14034 FM, 7965 RA, and 331 FM+RA patients. Patients with FM had a higher prevalence of several comorbidities and greater emergency department (ED) utilization than those with RA. Mean annual expenditures for FM patients were $10911 (SD=$16075). RA patient annual expenditures were similar to FM: $10716 (SD= $16860). Annual expenditures were almost double in patients with FM+RA ($19395, SD= $25440). A greater proportion of patients with FM had any short-term disability days than those with RA (20 vs. 15%); and a greater proportion of patients with RA had any absence days (65 vs. 80%). Mean costs for absence from work and short-term disability in the FM and RA groups were substantial and similar. The FM+RA group was of insufficient sample size to report on work loss. LIMITATIONS: The availability of newer and more expensive FDA-approved medications since 2004 is not reflected in our findings. This analysis was restricted to commercially insured patients and therefore may not be generalizable to the entire U.S. population. CONCLUSIONS: The burden of illness in FM is substantial and comparable to RA. Patients with FM incurred direct costs approximately equal to RA patients. Patients with FM had more ED, physician, and physical therapy visits than RA patients. Patients in both groups had several comorbidities. Patients with FM+RA incurred direct costs almost double those of the patients with either diagnosis alone. FM and RA patients incurred similar overall absence and short-term disability costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lost productive time and cost due to common pain conditions in the US workforce
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.290.18.2443 · Cited by 1,570
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Boonen, A., van den Heuvel, R., van Tubergen, A., Goossens, M., Severens, J. L., van der Heijde, D., & van der Linden, S. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.019711 · Cited by 219
Cited by
Exercise for Adults with Fibromyalgia: An Umbrella Systematic Review with Synthesis of Best Evidence
Bidonde, J., Busch, A., Bath, B., & Milosavljevic, S. (2014) · Current Rheumatology Reviews · doi:10.2174/1573403x10666140914155304 · Cited by 132
Burden of fibromyalgia and comparisons with osteoarthritis in the workforce
Kleinman, N., Harnett, J., Melkonian, A., Lynch, W., Kaplan-Machlis, B., & Silverman, S. L. (2009) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e3181bb808b · Cited by 62
Self-citationWagner, J.-S., DiBonaventura, M. D., Chandran, A. B., & Cappelleri, J. C. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-199 · Cited by 58
“Indeed, prior research on managed care patients with FM found an average of $10,911 (standard deviation = $16,860) in healthcare expenses per patient per year during 2001–2004 [4].”
BackgroundDuloxetine for the treatment of fibromyalgia
Wright, C. L., Mist, S. D., Ross, R. L., & Jones, K. D. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.64 · Cited by 43
Disability in Fibromyalgia Associates with Symptom Severity and Occupation Characteristics
Fitzcharles, M.-A., Ste-Marie, P. A., Rampakakis, E., Sampalis, J. S., & Shir, Y. (2016) · The Journal of Rheumatology · doi:10.3899/jrheum.151041 · Cited by 34
“814 Exercise activity 75 (30) 37 (41) 21 (26)* 17 (22)* 0.”
Metadata
- Authors
- Silverman, S., Dukes, E. M., Johnston, S. S., Brandenburg, N. A., Sadosky, A., & Huse, D. M.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa Healthcare
- Published
- 2009-02-17
- Volume
- 25
- Issue
- 4
- Pages
- 829-840
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2116832351
- Cited by
- 117
- References
- 3
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. https://app.cochat.ai/papers/10.1185/03007990902728456
- The paper
- Silverman, S., Dukes, E. M., Johnston, S. S., Brandenburg, N. A., Sadosky, A., & Huse, D. M. (2009). The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Current Medical Research and Opinion. https://doi.org/10.1185/03007990902728456
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.